Published in Vaccine Weekly, June 12th, 2002
This data showed that the symptoms of autoimmune myocarditis in a mouse model can be significantly reduced by immunization with a compound developed by CEL-SCI. These findings may lead to the preparation of a therapeutic vaccine, which could reduce the severity and/or prevent progression of autoimmune myocarditis.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly